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Chylothorax is characterized by accumalation of milky ﬂuid called chyle into the plural space. Most
common causes of cyhlothorax are trauma or surgery of thoracic duct and malignancies. Among the
malignancies lymphoma is responsible approximately 70% of cyhlothorax but other lymphocytic tumors
including chronic lymphocytic leukemia (CLL) is rarely reported. A 71 years old man with known CLL,
presented with dispnea and pleural effusion and diagnosed cyhlothorax due to leukemic inﬁltration that
conﬁrmed by immuno ﬂow cytometric analyse.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Chylothorax is characterized by lymphatic ﬂuid that enriched
with fat and its digestive products absorbed by the intestinal
epithelium, called chyle, into the pleural space [1]. The leakage of
chyle into the pleural space is the main mechanism underlying
chylothorax and is usually due to thoracic duct disruption [1,2]. A
triglyceride levels of >110 mg/dl or presence of chylomicrons [1,2].
Thoracic surgery that includes dissection of the mediastinum is the
most frequent cause of cyhlothorax [1]. Malignant obstruction of
the thoracic duct is the most frequent cause of nontraumatic chy-
lothorax. Lymphoma is the most common cause of neoplastic eti-
ologies of chylothorax (70% of cases) [1]. Chronic lymphocytic
leukemia (CLL) is an indolent type of B-cell non-Hodgkin's lym-
phoma that can be found in the bone marrow and blood, or pre-
dominantly in lymph nodes [3]. Pleural effusion occurs commonly
in non-Hodgkin's lymphoma, but is less often in CLL [7]. Here, we
present a case of chylothorax in a patient with CLL which was
diagnosed by immunoﬂow cytometric analyses.Faculty of Medicine, Depart-
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A 71 years old, man presented with dispnea which had been
increased for a few month. Patient declined chest pain, hemoptysi
and cough. The patient's history revelaed that, he had diagnosed
Becell CLL 7 years ago and still being treated with ﬂudarabinewith
the diagnosis of a stage 3e4 CLL. He had received last chemo-
therapy one month ago before the hospital admition. Physical ex-
amination revealed body temperature: 36.8 C, heart rate: 88/bpm,
tension arterial: 110/70mmHg and saturation O2:88%. Therewas no
breath sound at right lung basillaries on auscultation. Chest radi-
ography revealed homogen density at right lower zone. Complete
blood count analyses revealed white blood count:5.200/103 uL,
haemoglobin: 9.9 g/dL, platelet count: 135.000/103 uL, absolute
neutrophil count:2.500 103/uL (55%), and lymphocyte count:
1.700 103/uL (32%). Moderate pleural effusion was detected on
contrast enhanced thorax computed tomography (Fig. 1).
Diagnostic thorasentesis was performed and a white, milky,
ﬂuid was aspirated. Laktate dehydrogenase: 363 U/L and 504 U/L,
total protein: 5.2 g/dL and 7.1 g/dL, trigliceride 575 mg/dL and
32 mg/dL, total cholesterol: 62 mg/dL and 110 mg/dL were found in
pleural ﬂuid and serum, respectively. The pleural ﬂuid was
exudative and cyhlothorax was diagnosed. Nil by mouth, central
venous catheterization and total parenteral nutrition was admin-
istered. Chest tube drenaige was performed. Cytologic analyses
showed no atypical or malignant cells. Acide fast bacilli was
negative. Repeated ﬂow cytometric analyses were appropriate with
B-cell CLL in both of blood and pleural ﬂuid (Table 1).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Thorax computed tomography shows moderate pleural effusion on right hemithorax and there is no enlarged lymph node in mediastene.
Table 1
Flow cytometric analyses of the patient's blood and pleural ﬂuid.
Blood Pleural ﬂuid
CD3 23.7% 88.9%
CD5þCD19 24.1% 89.1%
CD4 11.5% 72.3%
CD8 15.0% 15.3%
CD4þCD8þ 0.1% 0.2%
CD19 69.7% 9.5%
CD5þCD19þ 69.1% 9.2%
CD20 57.9% 5.4%
CD22 68.8% 7.2%
CD20 þ 22 57.3% 4.2%
CD23 37.3% 3.4%
HLA-DR 76.6% 17.3%
CD34 0.3% Negative
CD11c 29.5% 4.9%
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chemotherapy regimen was started. Talk pleurodesis was per-
formed after daily ﬂuid drainage decreased 50 mg/day and chest
tube was removed. But the patient had poor prognosis and died 6
months later despite new chemotherapy regimen was
administered.3. Discussion
The chyle is a bacteriostatic, nonirritating, milky ﬂuid, which is
transported by thoracic duct into the systemic venous system from
intestines, liver, and lower extremities [1,2]. Obstruction or trauma
of thoracic duct lead to leakage of chyle into the pleural spaces [1].
The etiology of chylothorax has been divided into four major cat-
egories: tumor, trauma, idiopathic andmiscellaneuous [4]. Dyspnea
and chest discomfort are the main symptoms in patients with
cyhlothorax. Differently from other pleural effuisons, pleuritic
chest pain and fever are uncommon because of chyle is not irri-
tating to the pleural surfaces [1]. The sole symptom in our patient
was dispnea and the patient declined chest pain and fever.
Lymphoma is the most common cause of malignancy associated
cyhlothorax in adult patients, for over 70e75% of cases [1,3]. Otherlmphocytic tumors, including CLL, are rarely reported [4]. In a
retrospective study [5], Teng et al. investigated 88 patients with
chylothorax and found that 18 (20%) were malignancy associated.
Among malignancy associated chylothorax 11 were lymhoma (6 of
11 had no mediastinal involvement) and 7 were solid malignancy
[5]. Diagnosis of cyhlothorax is conﬁrmed when the chylomicrons
are found in pleural ﬂuid or the triglyceride levels are >110 mg/dL
in the pleural ﬂuid [3]. A triglyceride level between 55 and 110 mg/
dl requires a lipoprotein analysis to detect chylomicrons [1]. In our
patient a milky, exudative ﬂuid was aspirated and triglyceride level
was determined as 575 mg/dL, thus the diagnosis of was cyhlo-
thorax was conﬁrmed.
Pleural effusions may be the ﬁrst presentation of a hematologic
malignancy or may develop during the course of the disease [6]. In
patients with non-Hodgkin lymphoma and Hodgkin disease pleural
effusions are reported with a frequency of 20% and 30%, respec-
tively [6]. In patients with malignancy, chylous pleural effusions are
usually associated with damage of the thoracic duct and related
lymphatic channels of the thorax, neck, and abdomen [7]. CLL
usually involves the peripheral blood and bone marrow but
involvement of the thorax, consisting of pulmonary inﬁltrates and
pleural effusion, rarely occur [2]. In pleural effusions due to inﬁl-
tration of CLL, the ﬂuid may be hemorrhagic and contains
numerous predominantly B cell lymphocytes [8]. The differential
diagnosis of pleural effusion in a patient with CLL includes infec-
tion, pleural involvement and lymphatic obstruction. Immuno-
phenotyping of chyle may have limited value in diagnosing
chylothorax in CLL patients [8]. Positivity of cell surface markers
including CD3, CD5, CD19, CD20, CD23, and sometimes CD43 are
useful for CLL [2]. In our patient there was no enlarged lymph-
adenopathy that lead to obstruction of thoracic duct and no evi-
dence of infection. Thus we used the ﬂow cytometric analyse of
pleural ﬂuid to conﬁrm that the cyhlothorax in our patients was
associated with leukemic inﬁltration. The result of the ﬂow cyto-
metric analyse was appropriate with B-cell CLL (The surface marker
identical for CLL including CD3, CD5, CD4, CD8 and CD19 were
detected positive in pleural ﬂuid).
Patients with pleural involvement by CLL usually have a long-
standing diagnosis of CLL and thus they may have a limited
H. Tanrıverdi et al. / Respiratory Medicine Case Reports 16 (2015) 131e133 133prognosis [6,7]. But the patients who had either successful thoracic
duct ligation, mediastinal irradiation or pleurodesis were reported
longer survival [6]. Our patient developed cyhlothorax 7th years of
disease course and despite successful treatment and pleurodesis,
he had a poor prognosis and died 6 months after cyhlothorax
developed.
Management of chylothorax should include aggressive nutri-
tional support to reverse hypovolaemia, immunosuppression, and
protein and electrolyte deﬁciencies. In the presence of large chy-
lothoraces that lead to respiratory distress therapeutic thoracent-
esis preferably intescostal chest tube drainage should be performed
initially. Low fatty diet or nil by mouth are advised in the presence
of extensive leakage of cyhle. Total parenteral nutrition is indicated
in the presence of chronic chylothoraxor rapid loss of nutrients into
the pleural space [1]. In our patient, interscostal tube dreinage was
preferred and total parentaral nutrition via central venous cat-
etherization and nil by mouth administered.
Cyhlothorax rarely occurs during the late course of CLL. Flow
cytometric analyse may have limited value in detecting leukemic
inﬁltration of pleural ﬂuid.References
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